ANCA defines the clinical disease manifestations of vasculitis.
Zhao
M H
MH
Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, UK.
Lockwood
C M
CM
D019268:Antibodies, Antineutrophil Cytoplasmic / Q000276:immunology*; D000918:Antibody Specificity; D015703:Antigens, CD / Q000276:immunology; D023181:Antimicrobial Cationic Peptides; D001324:Autoantigens / Q000276:immunology*; D001798:Blood Proteins / Q000276:immunology; D002352:Carrier Proteins; D023082:Defensins; D006801:Humans; D051907:Lysosomal Membrane Proteins; D008562:Membrane Glycoproteins / Q000276:immunology; D053146:Myeloblastin; D009195:Peroxidase / Q000276:immunology; D012697:Serine Endopeptidases / Q000276:immunology; D014657:Vasculitis / Q000276:immunology*
C062991:AZU1 protein, human; D019268:Antibodies, Antineutrophil Cytoplasmic; D015703:Antigens, CD; D023181:Antimicrobial Cationic Peptides; D001324:Autoantigens; D001798:Blood Proteins; D002352:Carrier Proteins; D023082:Defensins; D051907:Lysosomal Membrane Proteins; D008562:Membrane Glycoproteins; C053368:cationic antimicrobial protein 57, human; D009195:Peroxidase; D012697:Serine Endopeptidases; D053146:Myeloblastin